Dexamethasone and Surgical-Site Infection

RCT (n=8725) found dexamethasone non-inferior to placebo in terms of incidence of surgical-site infection within 30 days after non-urgent, non-cardiac surgery (8.1% vs. 9.1%, respectively, risk difference adjusted for diabetes, −0.9%; 95.6% CI,−2.1 to 0.3; p<0.001,noninferiority)

New England Journal of Medicine